Health Canada - Federal department responsible for drug approvals and health regulation in Canada
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| EVRYSDI | HOFFMANN-LA ROCHE LIMITED | Marketed | Nov 27, 2025 | Marketed |
| TREOSULFAN FOR INJECTION | MARCAN PHARMACEUTICALS INC | Marketed | Nov 26, 2025 | Marketed |
| LYVDELZI | GILEAD SCIENCES CANADA INC | Marketed | Nov 25, 2025 | Marketed |
| DOXYCYCLINE FOR INJECTION USP | STERIMAX INC | Marketed | Nov 24, 2025 | Marketed |
| PRUCALOPRIDE | SANIS HEALTH INC | Marketed | Nov 19, 2025 | Marketed |
| PRUCALOPRIDE | SANIS HEALTH INC | Marketed | Nov 19, 2025 | Marketed |
| RIVA-TELMISARTAN/AMLODIPINE | LABORATOIRE RIVA INC. | Marketed | Nov 13, 2025 | Marketed |
| BRAVECTO QUANTUM | INTERVET CANADA CORP | Marketed | Nov 7, 2025 | Marketed |
| RIVA-RUPATADINE | LABORATOIRE RIVA INC. | Marketed | Nov 5, 2025 | Marketed |
| OSENVELT | CELLTRION INC. | Marketed | Oct 30, 2025 | Marketed |
| CALF-QUENCH HE | DOMINION VETERINARY LABORATORIES LTD. | Marketed | Oct 30, 2025 | Marketed |
| STOBOCLO | CELLTRION INC. | Marketed | Oct 30, 2025 | Marketed |
| ANDEMBRY | CSL BEHRING CANADA INC | Marketed | Oct 24, 2025 | Marketed |
| YESINTEK | Biosimilar Collaborations Ireland Ltd. | Marketed | Oct 24, 2025 | Marketed |
| YESINTEK | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | Marketed | Oct 24, 2025 | Marketed |
| YESINTEK I.V. | BIOSIMILAR COLLABORATIONS IRELAND LIMITED | Marketed | Oct 24, 2025 | Marketed |
| OMVOH | ELI LILLY CANADA INC | Marketed | Oct 22, 2025 | Marketed |
| OMVOH | ELI LILLY CANADA INC | Marketed | Oct 22, 2025 | Marketed |
| OMVOH | ELI LILLY CANADA INC | Marketed | Oct 22, 2025 | Marketed |
| OMVOH | ELI LILLY CANADA INC | Marketed | Oct 22, 2025 | Marketed |
